HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toward the optimal dose metric in continuous renal replacement therapy.

AbstractPURPOSE:
There is no consensus on the optimal method to measure delivered dialysis dose in patients with acute kidney injury (AKI). The use of direct dialysate-side quantification of dose in preference to the use of formal blood-based urea kinetic modeling and simplified blood urea nitrogen (BUN) methods has been recommended for dose assessment in critically-ill patients with AKI. We evaluate six different blood-side and dialysate-side methods for dose quantification.
METHODS:
We examined data from 52 critically-ill patients with AKI requiring dialysis. All patients were treated with pre-dilution CVVHDF and regional citrate anticoagulation. Delivered dose was calculated using blood-side and dialysis-side kinetics. Filter function was assessed during the entire course of therapy by calculating BUN to dialysis fluid urea nitrogen (FUN) ratios q/12 hours.
RESULTS:
Median daily treatment time was 1,413 min (1,260-1,440). The median observed effluent volume per treatment was 2,355 mL/h (2,060-2,863) (p<0.001). Urea mass removal rate was 13.0 ± 7.6 mg/min. Both EKR (r²=0.250; p<0.001) and KD (r²=0.409; p<0.001) showed a good correlation with actual solute removal. EKR and KD presented a decline in their values that was related to the decrease in filter function assessed by the FUN/BUN ratio.
CONCLUSIONS:
Effluent rate (mL/kg/h) can only empirically provide an estimated of dose in CRRT. For clinical practice, we recommend that the delivered dose should be measured and expressed as KD. EKR also constitutes a good method for dose comparisons over time and across modalities.
AuthorsRolando Claure-Del Granado, Etienne Macedo, Glenn M Chertow, Sharon Soroko, Jonathan Himmelfarb, T Alp Ikizler, Emil P Paganini, Ravindra L Mehta
JournalThe International journal of artificial organs (Int J Artif Organs) Vol. 35 Issue 6 Pg. 413-24 (Jun 2012) ISSN: 1724-6040 [Electronic] United States
PMID22466995 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Research Support, N.I.H., Extramural)
Chemical References
  • Biomarkers
  • Dialysis Solutions
  • Membranes, Artificial
  • Urea
  • Creatinine
Topics
  • Acute Kidney Injury (blood, physiopathology, therapy)
  • Adult
  • Biomarkers (blood)
  • Blood Urea Nitrogen
  • Creatinine (blood)
  • Critical Illness
  • Dialysis Solutions (administration & dosage, metabolism)
  • Equipment Design
  • Female
  • Humans
  • Kinetics
  • Male
  • Membranes, Artificial
  • Middle Aged
  • Models, Biological
  • Renal Dialysis (instrumentation, methods)
  • Treatment Outcome
  • United States
  • Urea (blood)
  • Urination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: